FEATURED COMPANIES
- Abbott Laboratories
- BGI Genomics
- F. Hoffmann-La Roche AG
- Quidel Corporation
COVID-19 rapid test kits opportunities and strategies to 2023: COVID-19 implications and growth provides the strategists, marketers and senior management with the critical information they need to assess the global COVID-19 rapid test kits market.
Reasons to Purchase
Description:
Where is the largest and fastest growing market for the COVID-19 rapid test kits market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? the COVID-19 rapid test kits global market opportunities and strategies to 2023: COVID-19 implications and growth answers all these questions and many more.
The report covers the following chapters
Markets Covered:
The global COVID-19 rapid test kits market is segmented into -
By Test Type: Rapid Antigen Test; Rapid Antibody Test; RT-PCR test; Others
By Kit Type: PCR Machines; Equipment and Extraction Kits; Reagents
By Specimen Type: Nasopharyngeal Swab; Oropharyngeal Swab; Nasal Swab; Blood; Others
By End-Users: Hospitals and Clinics; Diagnostic Laboratories; Home Care; Others
Companies Mentioned: F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; Abbott Laboratories; Quidel Corporation; BGI Genomics
Countries: China, Australia, India, Indonesia, Japan , South Korea, USA, Brazil, France, Germany, UK, Russia
Regions: Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Time series: Four years forecast period
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita
Data segmentations: country and regional forecast data, market share of competitors, market
Reasons to Purchase
- Outperform competitors using accurate up to date demand-side dynamics information.
- Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
- Identify growth segments for investment.
- Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
- Create regional and country strategies on the basis of local data and analysis.
- Stay abreast of the latest customer and market research findings
- Benchmark performance against key competitors.
- Develop strategies based on likely future developments.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Gain a global perspective on the development of the market.
Description:
Where is the largest and fastest growing market for the COVID-19 rapid test kits market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? the COVID-19 rapid test kits global market opportunities and strategies to 2023: COVID-19 implications and growth answers all these questions and many more.
The report covers the following chapters
- Executive Summary - the executive summary section of the report gives a brief overview and summary of the report
- Report Structure - This section gives the structure of the report and the information covered in the various sections.
- Introduction - the introduction section of the report gives brief introduction about segmentation by geography, segmentation by type, by distribution channel, by route of administration and by drug classification.
- Market Characteristics - the market characteristics section of the report defines and explains the oncology drugs market. This chapter also defines and describes goods and related services covered in the report.
- Trends and Strategies - This chapter describes the major trends shaping the global COVID-19 rapid test kits market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.
- COVID-19 Impact - This section describes the impact of COVID-19 on the market.
- Global Market Size and Growth - This section contains the global forecast (2019-2023),market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
- Regional Analysis - This section contains the forecast (2020-2023) market values and growth and market share comparison by region.
- Segmentation - This section contains the market values (2020-2030) and analysis for different segments.
- Regional Market Size and Growth - This section contains the region’s market size (2020), and forecast (2020-2023) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, South America, Middle East and Africa and major countries within each region. the market overview sections of the report describe the current size of the market, background information, government initiatives, regulations, regulatory bodies, associations, corporate tax structure, investments, and major companies.
- Competitive Landscape - This section covers details on the competitive landscape of the global COVID-19 rapid test kits market, estimated market shares and company profiles for the leading players.
- Key Mergers and Acquisitions - This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
- Market Opportunities and Strategies - This section includes market opportunities and strategies based on findings of the research. This section also gives information on growth opportunities across countries, segments and strategies to be followed in those markets. it gives an understanding of where there is significant business to be gained by competitors in the next three years.
- Conclusions and Recommendations - This section includes conclusions and recommendations based on findings of the research. This section also gives recommendations for COVID-19 rapid test kits companies in terms of product offerings, geographic expansion, price offerings, marketing strategies and target groups.
- Appendix - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
Markets Covered:
The global COVID-19 rapid test kits market is segmented into -
By Test Type: Rapid Antigen Test; Rapid Antibody Test; RT-PCR test; Others
By Kit Type: PCR Machines; Equipment and Extraction Kits; Reagents
By Specimen Type: Nasopharyngeal Swab; Oropharyngeal Swab; Nasal Swab; Blood; Others
By End-Users: Hospitals and Clinics; Diagnostic Laboratories; Home Care; Others
Companies Mentioned: F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; Abbott Laboratories; Quidel Corporation; BGI Genomics
Countries: China, Australia, India, Indonesia, Japan , South Korea, USA, Brazil, France, Germany, UK, Russia
Regions: Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Time series: Four years forecast period
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita
Data segmentations: country and regional forecast data, market share of competitors, market
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- Abbott Laboratories
- BGI Genomics
- F. Hoffmann-La Roche AG
- Quidel Corporation
1. COVID-19 Rapid Test Kits Market Executive Summary2. Table of Contents3. List of Figures4. List of Tables5. Report Structure
6. Introduction
7. COVID-19 Rapid Test Kits Market Characteristics
8. COVID-19 Rapid Test Kits Market Trends And Strategies
9. COVID-19 Rapid Test Kits Market, COVID Impact Analysis
10. Global COVID-19 Rapid Test Kits Market Size And Growth
11. Global COVID-19 Rapid Test Kits Market Segmentation
12. COVID-19 Rapid Test Kits Market, Regional And Country Analysis
13. Asia-Pacific COVID-19 Rapid Test Kits Market
14. Western Europe COVID-19 Rapid Test Kits Market
15. Eastern Europe COVID-19 Rapid Test Kits Market
16. North America COVID-19 Rapid Test Kits Market
17. South America COVID-19 Rapid Test Kits Market
18. Middle East COVID-19 Rapid Test Kits Market
19. Africa COVID-19 Rapid Test Kits Market
20. Global COVID-19 Rapid Test Kits Market Competitive Landscape
21. COVID-19 Rapid Test Kits Market, Key Collaborations
22. COVID-19 Rapid Test Kits Market Opportunities And Strategies
23. COVID-19 Rapid Test Kits Market, Conclusions And Recommendations
24. Appendix
Note: Product cover images may vary from those shown
LOADING...
FEATURED COMPANIES
- Abbott Laboratories
- BGI Genomics
- F. Hoffmann-La Roche AG
- Quidel Corporation
This report covers one four-year period, 2020 to 2023 forecast period. The report evaluates the market across each region as well as for the major economies within each region.
The COVID-19 rapid test kits market consists of sales of COVID-19 rapid test kits and related services by entities (organizations, sole traders and partnerships) that offer detection of COVID-19. The global COVID-19 rapid test kits market is expected to reach a value of nearly $14,941.3 million in 2020. The market is expected to decline from $14,941.3 million in 2020 to $1,367.3 million in 2023 at a rate of -54.9%. The market is expected to cease from 2024 due to the vaccination of global population by the end of 2023.
Going forward, impact of COVID-19, aging population, technological advances, increase in healthcare access and rising prevalence of chronic diseases are expected to drive the market. High costs of tests, product recalls, geopolitical tensions, growing corruption, launch of vaccines, use of masks, and low awareness/reluctance of testing, low healthcare access are major factors that could hinder the growth of the COVID-19 rapid test kits market in the future.
The COVID-19 rapid test kits market is segmented by test type into rapid antigen test, rapid antibody test, RT-PCR test and others. The RT-PCR wil be the largest segment of the COVID-19 rapid test kits market by test type, accounting for 84.3% of the total market in 2020.
The COVID-19 rapid test kits market is also segmented by kit type into equipment and extraction kits, PCR machines, and reagents. The PCR machines will be the largest segment of the COVID-19 rapid test kits market by kit type, accounting for 72.3% of the total market in 2020.
The COVID-19 rapid test kits market is also segmented by specimen type into nasopharyngeal swab, oropharyngeal swab, nasal swab, blood and others. The nasopharyngeal swab will be the largest segment of the COVID-19 rapid test kits market by specimen type, accounting for 55.2% of the total market in 2020
The COVID-19 rapid test kits market is also segmented by end-users into hospitals and clinics, diagnostic laboratories, home care and others. The hospitals and clinics will be the largest segment of the COVID-19 rapid test kits market by end-users, accounting for 57.1% of the total market in 2020.
North America was the largest region in the global COVID-19 rapid test kits market, accounting for 27.6% of the total in 2020. It was followed by the Asia Pacific, Western Europe, and then the other regions.
The COVID-19 rapid test kits market is fragmented, with a large number of large of small players in the market. Major players in the market include F. Hoffmann-La Roche AG, Thermo Fisher Scientific, Quidel Corporation, BGI Genomics, Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, Sysmex Corporation, Eiken Chemical. Market-trend-based strategies for the COVID-19 rapid test kits market includes collaborate with Artificial Intelligence companies, incorporating big data, developing rapid test kits with low test wait times, developing at-home rapid test kits, developing low cost test kits and collaborating with the government to quickly increase their production and to grow their customer base. Player-adopted strategies in the COVID-19 rapid test kits market include offering new products, increasing production and increasing partnerships with governments across the globe and private laboratories.
To take advantage of the opportunities, the publisher recommends the COVID-19 rapid test kits companies to focus on developing at home test kits, and focus on big data and AI to understand the gap between demand and supply of test kits and to improve the diagnosis. Also, the companies should focus on leveraging e-commerce to maximize their reach and promote their product by increasing visibility on business websites and participation in trade shows.
The COVID-19 rapid test kits market consists of sales of COVID-19 rapid test kits and related services by entities (organizations, sole traders and partnerships) that offer detection of COVID-19. The global COVID-19 rapid test kits market is expected to reach a value of nearly $14,941.3 million in 2020. The market is expected to decline from $14,941.3 million in 2020 to $1,367.3 million in 2023 at a rate of -54.9%. The market is expected to cease from 2024 due to the vaccination of global population by the end of 2023.
Going forward, impact of COVID-19, aging population, technological advances, increase in healthcare access and rising prevalence of chronic diseases are expected to drive the market. High costs of tests, product recalls, geopolitical tensions, growing corruption, launch of vaccines, use of masks, and low awareness/reluctance of testing, low healthcare access are major factors that could hinder the growth of the COVID-19 rapid test kits market in the future.
The COVID-19 rapid test kits market is segmented by test type into rapid antigen test, rapid antibody test, RT-PCR test and others. The RT-PCR wil be the largest segment of the COVID-19 rapid test kits market by test type, accounting for 84.3% of the total market in 2020.
The COVID-19 rapid test kits market is also segmented by kit type into equipment and extraction kits, PCR machines, and reagents. The PCR machines will be the largest segment of the COVID-19 rapid test kits market by kit type, accounting for 72.3% of the total market in 2020.
The COVID-19 rapid test kits market is also segmented by specimen type into nasopharyngeal swab, oropharyngeal swab, nasal swab, blood and others. The nasopharyngeal swab will be the largest segment of the COVID-19 rapid test kits market by specimen type, accounting for 55.2% of the total market in 2020
The COVID-19 rapid test kits market is also segmented by end-users into hospitals and clinics, diagnostic laboratories, home care and others. The hospitals and clinics will be the largest segment of the COVID-19 rapid test kits market by end-users, accounting for 57.1% of the total market in 2020.
North America was the largest region in the global COVID-19 rapid test kits market, accounting for 27.6% of the total in 2020. It was followed by the Asia Pacific, Western Europe, and then the other regions.
The COVID-19 rapid test kits market is fragmented, with a large number of large of small players in the market. Major players in the market include F. Hoffmann-La Roche AG, Thermo Fisher Scientific, Quidel Corporation, BGI Genomics, Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, Sysmex Corporation, Eiken Chemical. Market-trend-based strategies for the COVID-19 rapid test kits market includes collaborate with Artificial Intelligence companies, incorporating big data, developing rapid test kits with low test wait times, developing at-home rapid test kits, developing low cost test kits and collaborating with the government to quickly increase their production and to grow their customer base. Player-adopted strategies in the COVID-19 rapid test kits market include offering new products, increasing production and increasing partnerships with governments across the globe and private laboratories.
To take advantage of the opportunities, the publisher recommends the COVID-19 rapid test kits companies to focus on developing at home test kits, and focus on big data and AI to understand the gap between demand and supply of test kits and to improve the diagnosis. Also, the companies should focus on leveraging e-commerce to maximize their reach and promote their product by increasing visibility on business websites and participation in trade shows.
Note: Product cover images may vary from those shown
A selection of companies mentioned in this report includes:
- F. Hoffmann-La Roche AG
- Thermo Fisher Scientific Inc.
- Abbott Laboratories
- Quidel Corporation
- BGI Genomics
Note: Product cover images may vary from those shown
LOADING...
![Blood Screening Market by Product (Reagents & Kits, Instruments, Software), Technology (NAAT [Real-time PCR], ELISA [CLIA, FIA, CI], Rapid Tests, Western Blotting, NGS), and End User (Blood Banks, Hospitals, Laboratories) - Global Forecast to 2027 - Product Image](http://www.researchandmarkets.com/product_images/11389/11389865_60px_jpg/blood_screening_market.jpg)
